secwatch.observer — SEC 8-K summary
======================================

Issuer:     FRACTYL HEALTH, INC. (GUTS)
CIK:        0001572616
Form:       8-K
Filed at:   2025-11-12T23:59:59+00:00
Accession:  0001193125-25-277524
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fractyl Health Q3 net loss $45.6M; Revita post-GLP-1 weight maintenance data positive
--------------------------------------------------------------------------------

- Net loss of $45.6M includes $23.5M non-cash warrant fair-value change; operating expenses down $1.1M YoY.
- R&D spend $17.5M vs $19.0M year-ago; SG&A $5.2M vs $4.8M.
- Cash $77.7M at Sep 30 2025; $83M in August/September offerings extend runway into early 2027.
- REMAIN-1 Midpoint Cohort met endpoint: Revita patients lost 2.5% additional weight vs 10% regain for sham (p=0.014).
- REMAIN-1 Pivotal enrollment >60% randomized; 6-month primary data expected H2 2026 with potential PMA filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1572616/000119312525277524/0001193125-25-277524-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1572616/000119312525277524/guts-20251112.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-277524

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer